Skip to main content
. 2022 Oct 6;21(2):259–266. doi: 10.1016/j.gpb.2022.09.012

Table 1.

The distribution of mutations and neoantigens across 16 tumor types

Mutation type Tissue No. of samples No. of mutations No. of neoantigens No. of neoantigens per mutation
SNV Bladder 408 74,707 21,070 0.38
Brain 151 16,197 5227
Breast 982 62,211 18,238
Cervix 286 46,607 11,906
Colorectal 531 165,293 39,116
Head and neck 495 55,968 13,728
Kidney 681 26,170 8499
Liver 358 28,024 5987
Lung 999 212,861 52,801
Ovary 305 28,478 7631
Pancreas 166 17,221 3985
Prostate 493 16,424 5363
Skin 466 206,907 43,882
Stomach 411 103,103 24,497
Thyroid 488 4425 1218
Uterus 528 415,499 109,125



INDEL Bladder 389 2890 3532 1.22
Brain 130 366 375
Breast 888 5207 6123
Cervix 257 3095 4234
Colorectal 520 21,327 29,876
Head and neck 478 3569 4913
Kidney 648 5318 6395
Liver 353 2120 2143
Lung 983 10,790 12,407
Ovary 296 4260 4441
Pancreas 141 457 806
Prostate 416 1448 2119
Skin 430 1965 2557
Stomach 393 19,912 24,838
Thyroid 248 1746 1657
Uterus 516 27,934 30,714



Fusion Bladder 269 809 819 0.88
Brain 92 244 245
Breast 787 3390 3457
Cervix 139 280 215
Colorectal 167 328 231
Head and neck 285 532 530
Kidney 171 318 420
Liver 179 513 423
Lung 716 1992 710
Ovary 316 983 609
Pancreas 72 130 161
Prostate 381 1079 1120
Skin 287 841 918
Stomach 178 559 486
Thyroid 110 140 250
Uterus 85 501 499

Note: SNV, single nucleotide variant; INDEL, insertion/deletion; Fusion, gene fusion.